The BRAIN Act (Bolstering Research And Innovation Now Act) is legislation designed to accelerate medical research and improve care for brain tumor patients, who currently face low survival rates that have remained largely unchanged for decades. The bill establishes several initiatives: it creates a searchable public database of brain tumor tissue samples collected with federal funding to facilitate research collaboration, launches a Glioblastoma Therapeutics Network to test new treatments from laboratory through early human trials, funds research into CAR-T cell therapy for brain tumors, and directs a national public awareness campaign about cancer clinical trials and biomarker testing. Additionally, the bill supports pilot programs to develop better monitoring and care approaches for brain tumor survivors and requires the FDA to issue guidance ensuring that brain tumor patients have better access to clinical trials. The legislation authorizes approximately $75 million in funding over fiscal years 2026 through 2030 to support these research and awareness initiatives.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.